| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 145,2 k € | -69.3% | 473,6 k € | +3.3% | 458,6 k € | +66.4% | 275,6 k € | -6.9% | 296,1 k € | +50.9% | 196,3 k € | +1.6% | 193,3 k € | +113.5% | 90,5 k € | -8.9% | 99,4 k € | -12.4% | 113,4 k € | +71.0% | 66,3 k € | -63.7% | 182,5 k € | +262.1% | 50,4 k € | -14.5% | 58,9 k € | -9.7% | 65,3 k € | -58.7% | 157,9 k € | |
| EBITDA | 141,3 k € | -70.0% | 471,2 k € | +3.2% | 456,4 k € | +66.9% | 273,5 k € | -6.7% | 293,3 k € | +50.4% | 195,1 k € | +1.7% | 191,8 k € | +115.0% | 89,2 k € | -9.0% | 98,0 k € | -12.4% | 111,9 k € | +74.3% | 64,2 k € | -64.6% | 181,5 k € | +267.3% | 49,4 k € | -13.6% | 57,2 k € | +23.7% | 46,2 k € | -70.5% | 156,5 k € | |
| Operating profit | 101,8 k € | -76.8% | 438,6 k € | +0.9% | 434,8 k € | +62.0% | 268,4 k € | -4.1% | 279,9 k € | +46.1% | 191,6 k € | +8.8% | 176,1 k € | +136.6% | 74,4 k € | -10.2% | 82,9 k € | -13.8% | 96,1 k € | +257.8% | 26,9 k € | -84.6% | 174,7 k € | +306.5% | 43,0 k € | -15.2% | 50,7 k € | +42.1% | 35,7 k € | -70.7% | 121,8 k € | |
| Profit/loss | 67,7 k € | -78.4% | 312,8 k € | -2.8% | 321,9 k € | +65.0% | 195,0 k € | -5.3% | 206,0 k € | +32.6% | 155,3 k € | +6.8% | 145,4 k € | +193.8% | 49,5 k € | -19.1% | 61,2 k € | -28.7% | 85,9 k € | +186.6% | 30,0 k € | -79.0% | 142,5 k € | +353.9% | 31,4 k € | -31.6% | 45,9 k € | +123.7% | 20,5 k € | -74.9% | 81,6 k € | |
| Equity | 1,3 M € | +5.5% | 1,2 M € | +28.7% | 953,1 k € | +39.8% | 681,7 k € | +19.7% | 569,5 k € | +40.5% | 405,4 k € | -7.2% | 437,0 k € | +24.3% | 351,6 k € | +12.7% | 312,1 k € | +7.3% | 290,9 k € | +14.1% | 255,1 k € | +4.1% | 245,1 k € | +47.0% | 166,7 k € | +7.3% | 155,3 k € | +35.7% | 114,5 k € | +21.8% | 94,0 k € | |
| Total assets | 1,5 M € | -2.3% | 1,5 M € | +15.9% | 1,3 M € | +40.6% | 947,0 k € | +21.7% | 778,1 k € | +38.6% | 561,5 k € | -22.5% | 724,6 k € | +54.3% | 469,7 k € | +0.1% | 469,4 k € | -1.0% | 474,2 k € | +11.9% | 423,7 k € | -1.2% | 428,9 k € | +102.8% | 211,5 k € | +14.9% | 184,0 k € | +37.2% | 134,1 k € | -6.0% | 142,6 k € | |
| Cash | 96,7 k € | -27.2% | 132,8 k € | -30.4% | 190,9 k € | -6.1% | 203,2 k € | -39.1% | 333,6 k € | +485.5% | 57,0 k € | -79.4% | 276,2 k € | +1491.2% | 17,4 k € | -57.6% | 40,9 k € | -41.4% | 69,8 k € | +323.2% | 16,5 k € | -92.8% | 227,9 k € | +29.1% | 176,5 k € | +15.7% | 152,6 k € | +68.1% | 90,8 k € | +5.6% | 86,0 k € | |
| Debts | 213,4 k € | -32.6% | 316,5 k € | -16.3% | 378,2 k € | +42.6% | 265,1 k € | +38.9% | 190,8 k € | +43.5% | 133,0 k € | -50.5% | 268,6 k € | +166.4% | 100,8 k € | -28.0% | 140,1 k € | -15.5% | 165,8 k € | +9.6% | 151,2 k € | -9.3% | 166,7 k € | +503.9% | 27,6 k € | +139.7% | 11,5 k € | +360.6% | 2,5 k € | -94.9% | 48,6 k € | |
Private limited company · Maldegem · incorporated on 06/02/2009
Private limited company profitable and well capitalised. Cash position declining (-27.2%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Dr B Lelie Patholoog is a Private limited company incorporated in 2009. Its registered office is in Maldegem.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette